Skip to main content
TipRanks
Go Ultimate75% OFF

Pharmacorp Rx Inc. (PCRX) Financial Statements

3 Followers

Pharmacorp Rx Inc. Financial Overview

Pharmacorp Rx Inc.'s market cap is currently $78.46M. The company's EPS TTM is ―; its P/E ratio is -50.62; Pharmacorp Rx Inc. is estimated to report earnings on November 26, 2026, and the estimated EPS forecast is $0.00. See an overview of income statement, balance sheet, and cash flow financials.

Financial overview
Dec 23Dec 22
Income Statement
Total Revenue――
Gross Profit――
Operating Income$ -577.96K$ -563.18K
EBITDA$ -470.43K$ -517.09K
Net Income$ -470.43K$ -517.09K
Balance Sheet
Cash & Short-Term Investments――
Total Assets$ 2.32M$ 2.73M
Total Debt$ 0.00$ 0.00
Net Debt$ -2.24M$ -2.73M
Total Liabilities$ 46.19K$ 16.46K
Stockholders' Equity――
Cash Flow
Free Cash Flow$ -519.46K$ -120.18K
Operating Cash Flow――
Investing Cash Flow――
Financing Cash Flow――

Currency in USD